ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

ClinicalTrials.gov ID: NCT05828082

Public ClinicalTrials.gov record NCT05828082. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 4:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study of M1774 in Refractory SPOP-Mutant Prostate Cancer

Study identification

NCT ID
NCT05828082
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
20 participants

Conditions and interventions

Interventions

  • Biopsy Procedure Procedure
  • Biospecimen Collection Procedure
  • Computed Tomography Procedure
  • Magnetic Resonance Imaging Procedure
  • Positron Emission Tomography Procedure
  • Tuvusertib Drug
  • Ultrasound Imaging Procedure

Procedure · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2023
Primary completion
Jun 17, 2026
Completion
Jun 17, 2026
Last update posted
Apr 13, 2026

2023 – 2026

United States locations

U.S. sites
26
U.S. states
12
U.S. cities
22
Facility City State ZIP Site status
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868
UM Sylvester Comprehensive Cancer Center at Aventura Aventura Florida 33180
UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables Florida 33146
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach Florida 33442
Mayo Clinic in Florida Jacksonville Florida 32224-9980
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136
Memorial Hospital East Shiloh Illinois 62269
University of Kansas Cancer Center Kansas City Kansas 66160
University of Kansas Hospital-Indian Creek Campus Overland Park Kansas 66211
University of Kansas Hospital-Westwood Cancer Center Westwood Kansas 66205
Mayo Clinic in Rochester Rochester Minnesota 55905
Siteman Cancer Center at Saint Peters Hospital City of Saint Peters Missouri 63376
Siteman Cancer Center at West County Hospital Creve Coeur Missouri 63141
Washington University School of Medicine St Louis Missouri 63110
Siteman Cancer Center-South County St Louis Missouri 63129
Siteman Cancer Center at Christian Hospital St Louis Missouri 63136
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232
UT Southwestern Simmons Cancer Center - RedBird Dallas Texas 75237
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390
UT Southwestern/Simmons Cancer Center-Fort Worth Fort Worth Texas 76104
UT Southwestern Clinical Center at Richardson/Plano Richardson Texas 75080
University of Virginia Cancer Center Charlottesville Virginia 22908
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center Madison Wisconsin 53718
University of Wisconsin Carbone Cancer Center - University Hospital Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05828082, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05828082 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →